-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Alnylam Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2020 to Q2 2024.
- Alnylam Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.13 USD/shares, a 94.1% increase year-over-year.
- Alnylam Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.56 USD/shares, a 93.5% increase year-over-year.
- Alnylam Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -3.52 USD/shares, a 62.2% increase from 2022.
- Alnylam Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -9.3 USD/shares, a 29.2% decline from 2021.
- Alnylam Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -7.2 USD/shares, a 3.49% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)